RU94046161A - Способы экспрессии, днк, кассета экспрессии, изолированный участок регуляции транскрипции, растение, семя, способ изменения метаболизма, часть растения, способ получения полипептидов - Google Patents

Способы экспрессии, днк, кассета экспрессии, изолированный участок регуляции транскрипции, растение, семя, способ изменения метаболизма, часть растения, способ получения полипептидов

Info

Publication number
RU94046161A
RU94046161A RU94046161/13A RU94046161A RU94046161A RU 94046161 A RU94046161 A RU 94046161A RU 94046161/13 A RU94046161/13 A RU 94046161/13A RU 94046161 A RU94046161 A RU 94046161A RU 94046161 A RU94046161 A RU 94046161A
Authority
RU
Russia
Prior art keywords
expression
plant
casette
seed
methods
Prior art date
Application number
RU94046161/13A
Other languages
English (en)
Other versions
RU2148647C1 (ru
Inventor
М.Молони Морис
Ca]
Original Assignee
Юниверсити Текнолоджиз Интернэшнл Инк. (CA)
Юниверсити Текнолоджиз Интернэшнл Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/CA1992/000161 external-priority patent/WO1993021320A1/en
Application filed by Юниверсити Текнолоджиз Интернэшнл Инк. (CA), Юниверсити Текнолоджиз Интернэшнл Инк. filed Critical Юниверсити Текнолоджиз Интернэшнл Инк. (CA)
Priority claimed from PCT/CA1993/000141 external-priority patent/WO1993020216A1/en
Publication of RU94046161A publication Critical patent/RU94046161A/ru
Application granted granted Critical
Publication of RU2148647C1 publication Critical patent/RU2148647C1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8222—Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8222—Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
    • C12N15/823—Reproductive tissue-specific promoters
    • C12N15/8234—Seed-specific, e.g. embryo, endosperm
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Abstract

Заявляются ДНК - конструкции, включающие 5' - нетранслированные последовательности генов, активных от поздних глобулярный стадий и вплоть до созревания эмбриона. Указанные конструкции можно использовать для экспрессии представляющих интерес ДНК - последовательностей в течение фаз эмбрионального развития, которые предшествуют стадии накопления запасных белков.

Claims (1)

  1. Заявляются ДНК - конструкции, включающие 5' - нетранслированные последовательности генов, активных от поздних глобулярный стадий и вплоть до созревания эмбриона. Указанные конструкции можно использовать для экспрессии представляющих интерес ДНК - последовательностей в течение фаз эмбрионального развития, которые предшествуют стадии накопления запасных белков.
RU94046161A 1992-04-02 1993-04-02 Способ экспрессии представляющей интерес последовательности днк в клетке семени, днк-конструкция, кассета экспрессии, изолированный регуляторный участок транскрипции и способ изменения специфичного для семян метаболизма RU2148647C1 (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US86235592A 1992-04-02 1992-04-02
US07/862,355 1992-04-02
WOPCT/CA92/00161 1992-04-15
PCT/CA1992/000161 WO1993021320A1 (en) 1991-02-22 1992-04-15 Oil-body proteins as carriers of high-value peptides in plants
PCT/CA1993/000141 WO1993020216A1 (en) 1991-02-22 1993-04-02 Oil-body protein cis-elements as regulatory signals

Publications (2)

Publication Number Publication Date
RU94046161A true RU94046161A (ru) 1997-05-10
RU2148647C1 RU2148647C1 (ru) 2000-05-10

Family

ID=25683013

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94046161A RU2148647C1 (ru) 1992-04-02 1993-04-02 Способ экспрессии представляющей интерес последовательности днк в клетке семени, днк-конструкция, кассета экспрессии, изолированный регуляторный участок транскрипции и способ изменения специфичного для семян метаболизма

Country Status (12)

Country Link
US (1) US5792922A (ru)
EP (1) EP0633940B1 (ru)
JP (1) JP3660354B2 (ru)
KR (1) KR100278456B1 (ru)
AT (1) ATE229076T1 (ru)
AU (1) AU678154B2 (ru)
DE (1) DE69332538T2 (ru)
ES (1) ES2187505T3 (ru)
FI (1) FI120314B (ru)
NO (1) NO321501B1 (ru)
RU (1) RU2148647C1 (ru)
UA (1) UA41319C2 (ru)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001042443A1 (fr) * 1999-12-09 2001-06-14 Institut Molekulyarnoi Biologii Im. V.A.Engelgardta Rossiiskoi Akademii Nauk Procede de modification des proprietes genetiques d'un organisme
RU2561463C2 (ru) * 2009-04-22 2015-08-27 Басф Плант Сайенс Компани Гмбх Промотор целого семени

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586661B1 (en) 1997-06-12 2003-07-01 North Carolina State University Regulation of quinolate phosphoribosyl transferase expression by transformation with a tobacco quinolate phosphoribosyl transferase nucleic acid
US6635806B1 (en) * 1998-05-14 2003-10-21 Dekalb Genetics Corporation Methods and compositions for expression of transgenes in plants
DE19923571A1 (de) * 1999-05-21 2000-11-23 Kws Saat Ag Nukleotid-Sequenz zur Erhöhung der Abwehrreaktion einer Pflanze gegen Pathogenbefall
US20030140372A1 (en) * 1999-06-07 2003-07-24 Shen Jennie Bih-Jien Genes for desaturases to alter lipid profiles in corn
US6784342B1 (en) 1999-08-04 2004-08-31 The University Of British Columbia Regulation of embryonic transcription in plants
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
AU8847801A (en) 2000-08-25 2002-03-04 Basf Plant Science Gmbh Plant polynucleotides encoding novel prenyl proteases
KR20030029885A (ko) * 2000-08-30 2003-04-16 노쓰 캐롤라이나 스테이트 유니버시티 단백질 함량을 변화시키는 분자 미끼를 포함하는유전자이식 식물
US20030167524A1 (en) * 2000-12-19 2003-09-04 Rooijen Gijs Van Methods for the production of multimeric protein complexes, and related compositions
KR20030066732A (ko) * 2000-12-19 2003-08-09 셈비오시스제네틱스인코포레이티드 다량체 단백질의 제조 방법 및 관련 조성물
AU2002309610A1 (en) 2001-04-24 2002-11-05 Cornell Research Foundation Inc. Synthetic nucleic acid molecule for imparting multiple traits
EP1401849A4 (en) * 2001-05-30 2005-05-18 Chromos Molecular Systems Inc ARTIFICIAL PLANT CHROMOSOMES, THEIR USE AND METHOD FOR THE MANUFACTURE OF ARTIFICIAL PLANT CHROMOSOMES
US20060179514A1 (en) * 2001-07-05 2006-08-10 Sembiosys Genetics, Inc. Methods for the production of multimeric protein complexes, and related compositions
CN105131104B (zh) 2001-10-10 2018-11-16 诺和诺德公司 肽的重构和糖缀合
NZ532027A (en) 2001-10-10 2008-09-26 Neose Technologies Inc Remodeling and glycoconjugation of peptides
AU2003245772A1 (en) 2002-06-28 2004-01-19 University Of Guelph Harvest-inducible genes form alfalfa (medicago sativa) and methods of use thereof
US7329798B2 (en) * 2002-06-28 2008-02-12 University Of Guelph Harvest-inducible regulatory elements and methods of using same
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US8119150B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US7645803B2 (en) 2005-05-09 2010-01-12 Foamix Ltd. Saccharide foamable compositions
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
MXPA05004278A (es) 2002-10-25 2005-10-05 Foamix Ltd Espuma cosmetica y farmaceutica.
BRPI0407487A (pt) 2003-02-14 2006-02-14 Biogen Idec Inc cassete e um vetor de expressão para a expressão transitória ou estável de moléculas exógenas
US20070026485A1 (en) 2003-04-09 2007-02-01 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
DE602004015980D1 (de) 2003-06-17 2008-10-02 Sembiosys Genetics Inc Verfahren zur insulinproduktion in pflanzen
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
EP1684603A2 (en) * 2003-10-02 2006-08-02 Vector Tobacco Ltd. Tobacco product labeling system
NZ563676A (en) 2005-05-23 2011-01-28 Arcadia Biosciences Inc Safflower with elevated gamma-linolenic acid
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US20090049569A1 (en) * 2007-08-13 2009-02-19 Pioneer Hi-Bred International, Inc. Seed-Preferred Regulatory Elements
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
EP2242476A2 (en) 2008-01-14 2010-10-27 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US20110126315A1 (en) * 2008-05-28 2011-05-26 Ikuko Nishimura Novel selection marker gene and use thereof
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
MX359879B (es) 2009-10-02 2018-10-12 Foamix Pharmaceuticals Ltd Composiciones tópicas de tetraciclina.
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ221259A (en) * 1986-07-31 1990-05-28 Calgene Inc Seed specific transcriptional regulation
AU3073592A (en) * 1991-11-15 1993-06-15 E.I. Du Pont De Nemours And Company Beta -ketoacyl-acp synthetase ii genes from plants

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001042443A1 (fr) * 1999-12-09 2001-06-14 Institut Molekulyarnoi Biologii Im. V.A.Engelgardta Rossiiskoi Akademii Nauk Procede de modification des proprietes genetiques d'un organisme
RU2561463C2 (ru) * 2009-04-22 2015-08-27 Басф Плант Сайенс Компани Гмбх Промотор целого семени
US10519458B2 (en) 2009-04-22 2019-12-31 Basf Plant Science Company Gmbh Whole seed specific promoter
US11629353B2 (en) 2009-04-22 2023-04-18 Basf Plant Science Company Gmbh Whole seed specific promoter

Also Published As

Publication number Publication date
UA41319C2 (ru) 2001-09-17
NO943664L (no) 1994-11-15
JP3660354B2 (ja) 2005-06-15
AU678154B2 (en) 1997-05-22
ATE229076T1 (de) 2002-12-15
JPH07505525A (ja) 1995-06-22
NO321501B1 (no) 2006-05-15
KR100278456B1 (ko) 2001-01-15
RU2148647C1 (ru) 2000-05-10
ES2187505T3 (es) 2003-06-16
FI944550A (fi) 1994-11-30
EP0633940B1 (en) 2002-12-04
DE69332538T2 (de) 2003-11-06
KR950700995A (ko) 1995-02-20
FI944550A0 (fi) 1994-09-30
NO943664D0 (no) 1994-09-30
DE69332538D1 (de) 2003-01-16
AU3884493A (en) 1993-11-08
FI120314B (fi) 2009-09-15
EP0633940A1 (en) 1995-01-18
US5792922A (en) 1998-08-11

Similar Documents

Publication Publication Date Title
RU94046161A (ru) Способы экспрессии, днк, кассета экспрессии, изолированный участок регуляции транскрипции, растение, семя, способ изменения метаболизма, часть растения, способ получения полипептидов
Sassa et al. Induction of δ-aminolevulinic acid synthetase in chick embryo liver cells in culture
Smith et al. Cellular localization of apolipoprotein D and lecithin: cholesterol acyltransferase mRNA in rhesus monkey tissues by in situ hybridization.
SEIJI et al. The reciprocal relationship between melanization and tyrosinase activity in melanosomes (melanin granules)
Toft et al. Reactivation of proliferin gene expression is associated with increased angiogenesis in a cell culture model of fibrosarcoma tumor progression
Teichert et al. In vivo expression profile of an endothelial nitric oxide synthase promoter-reporter transgene
DK0472712T3 (da) Sekvenser, der præferentielt eksprimeres i tidlig frøudvikling og dertil relaterede fremgangsmåder
DE69429337T2 (de) Verfahren zur verabreichung von förderlichen zusammensetzungen auf die haarfollikel
DE69733572D1 (de) Vererbliches hemochromatosis-gen
Fouquet et al. Expression of intermediate filament proteins during development of Xenopus laevis III. Identification of mRNAs encoding cytokeratins typical of complex epithelia
ATE369430T1 (de) Methoden zur herstellung von nukleotidintegrasen
Pittoggi et al. Specific localization of transcription factors in the chromatin of mouse mature spermatozoa
DE69718052D1 (de) Menschliches wachstumsgen und minderwuchse gen bereich
Higuchi et al. [42] Senescence-accelerated mouse
FR2826010A1 (fr) Oligonucleotides antisens capables d'inhiber la formation des tubes capillaires par les cellules endotheliales
WO2001090386A3 (en) Gene regulatory region that promotes early seed-specific transcription
Scheurlen et al. Presence and expression of G2 cyclins in the coelenterate hydra
Vijayasaradhi et al. Melanoma and melanocytes: pigmentation, tumor progression, and the immune response to cancer
WO1999015668A3 (en) Banana proteins, dna, and dna regulatory elements associated with fruit development
WO1996035791A1 (fr) Sequence d'adn codant pour un ribozyme a titre de medicament, et compositions pharmaceutiques la contenant
Fan et al. In vivo alteration of the keratin 17 gene in hair follicles by oligonucleotide‐directed gene targeting
DE69840502D1 (de) Zubereitungen und verfahren zur aktivierung bestimmter gene
WO2000030590A3 (en) Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2
Akasaka et al. Purification of Acetylcholinesterase from Sea Urchin (Hemicentrotus pulcherrimus) Embryos by Affinity Chromatography: (acethylcholinesterase/purification/Sea Urchin, Hemicentrotus pulcherrimus)
Park et al. Identification of an Enhancer Critical for the ephirn-A5 Gene Expression in the Posterior Region of the Mesencephalon